Celgene's Revlimid meets study goal of slowing multiple myel
Publicado: Vie Dic 18, 2009 7:20 pm
Celgene's Revlimid meets study goal of slowing multiple myeloma progression
Fuente:
Los Angeles Times
By Associated Press
December 18, 2009 | 5:28 a.m
"The study is being conducted by the National Cancer Institute, which is part of the National Institutes of Health. It involves patients who have received autologous stem cell transplants, a procedure where stem cells are removed from a person's bone marrow prior to chemotherapy, then reintroduced after chemotherapy. The goal is for the stem cells to produce healthy new blood cells."
Leer mas en:
http://www.latimes.com/business/nationw ... 1291.story
un abrazo
Link de la traducción:
http://translate.google.es/translate?js ... l=en&tl=es
Fuente:
Los Angeles Times
By Associated Press
December 18, 2009 | 5:28 a.m
"The study is being conducted by the National Cancer Institute, which is part of the National Institutes of Health. It involves patients who have received autologous stem cell transplants, a procedure where stem cells are removed from a person's bone marrow prior to chemotherapy, then reintroduced after chemotherapy. The goal is for the stem cells to produce healthy new blood cells."
Leer mas en:
http://www.latimes.com/business/nationw ... 1291.story
un abrazo
Link de la traducción:
http://translate.google.es/translate?js ... l=en&tl=es